financetom
Business
financetom
/
Business
/
Quantum eMotion Awarded $1.2 Million NSERC Grant
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quantum eMotion Awarded $1.2 Million NSERC Grant
Mar 28, 2024 11:25 AM

02:07 PM EDT, 03/28/2024 (MT Newswires) -- Quantum eMotion Corp. ( QNCCF ) said Thursday that it has received a research grant of $1.2 million, by the Alliance Quantum grants program, overseen by the Natural Sciences and Engineering Research Council of Canada (NSERC). This grant supports the project "Quantum random number generation for highly secure cryptography applications," a collaborative initiative led by Ecole de Technologie Superieure (ETS), in partnership with QeM.

The collaboration between ETS and QeM will target technical challenges in the commercialization of quantum random number generator (QRNG) technologies, particularly the reduction of energy consumption while ensuring premier security features through quantum tunneling-based encryption methods, the statement added.

Price: 0.16, Change: +0.02, Percent Change: +14.81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CSG raises cash component for Vista Outdoor's arms unit
CSG raises cash component for Vista Outdoor's arms unit
Sep 13, 2024
Sept 13 (Reuters) - Vista Outdoor ( VSTO ) said on Friday Czechoslovak Group (CSG) has increased its offer to buy the arms business to $28 per share and that CSG would also purchase 7.5% of the company's Revelyst unit for $150 million. ...
Why Is Nanocap Immuneering Stock Trading Higher On Friday?
Why Is Nanocap Immuneering Stock Trading Higher On Friday?
Sep 13, 2024
On Thursday, Immuneering Corporation ( IMRX ) released initial response data from the first five patients treated with IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer as part of its ongoing Phase 2a trial. The first two patients in the Phase 2a arm evaluating IMM-1-104 with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer have recorded complete or partial responses...
Jacobs Solutions to Spin-Off Critical Mission Solutions, Cyber & Intelligence Businesses on Sept. 23
Jacobs Solutions to Spin-Off Critical Mission Solutions, Cyber & Intelligence Businesses on Sept. 23
Sep 13, 2024
09:01 AM EDT, 09/13/2024 (MT Newswires) -- Jacobs Solutions ( J ) said Friday it will spin off its Critical Mission Solutions and Cyber & Intelligence government services businesses on Sept. 23. The company will merge its spin-off business with Amentum, which is expected to be completed on Sept. 27, to form a new public company and list its shares...
Explainer-How DSV grew into the world's biggest logistics firm
Explainer-How DSV grew into the world's biggest logistics firm
Sep 13, 2024
COPENHAGEN (Reuters) - DSV is on the verge of becoming the world's biggest logistics firm after agreeing to buy Schenker, the logistics arm of German state rail operator Deutsche Bahn, for 14.3 billion euros ($15.85 billion). DSV, a logistics firm that started as a small enterprise of 10 truckers in 1976, has grown rapidly through a string of successful acquisitions...
Copyright 2023-2026 - www.financetom.com All Rights Reserved